Dr Kash Bhatti presents five key learning points from updated Primary Care Dermatology Society guidance on eczema in adults and children

Implementation actions for STPs and ICSs

written by Dr David Jenner, GP, Cullompton, Devon

The following implementation actions are designed to support STPs and ICSs with the challenges involved with implementing new guidance at a system level. Our aim is to help you consider how to deliver improvements to healthcare within the available resources. 

•    Circulate the PCDS eczema pathways widely among primary care health professionals and community pharmacies

•    Update local formularies to include a range of emollients and anti-inflammatory agents, ideally of low acquisition cost

•    Publish self-help guides for patients on trigger avoidance and to support adherence to prescribed medications

•    Design and circulate local care pathways that identify when patients should be referred to secondary or specialist care, and how this should be done.

STP=sustainability and transformation partnership; ICS=integrated care system; PCDS=Primary Care Dermatology Society


  1. Ingram J. Chapter 39: Eczematous disorders. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. 9th ed. Chichester: Wiley-Blackwell, 2016: 39.1–39.9.
  2. Cork M, Danby S, Ogg G. Atopic dermatitis epidemiology and unmet need in the United Kingdom. J Dermatolog Treat 2019; 1–9. doi: 10.1080/09546634.2019.1655137.
  3. Tsakok T, Woolf R, Smith C et al. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol 2019; 180 (3): 464–474.
  4. NICE. Atopic eczema in under 12s: diagnosis and management. NICE Clinical Guideline 57. NICE, 2007 (update in progress). Available at: www.nice.org.uk/guidance/cg57
  5. SIGN. Management of atopic eczema in primary care. SIGN 125. SIGN, 2011. Available at: www.sign.ac.uk/sign-125-management-of-atopic-eczema-in-primary-care.html
  6. Primary Care Dermatology Society. Eczema – paediatric (0–12yrs) – primary care treatment pathway. PCDS, 2019. Available at: www.pcds.org.uk/ee/images/uploads/general/Paediatric_Eczema_Pathway-web.pdf
  7. Primary Care Dermatology Society. Eczema – adult – primary care treatment pathway. PCDS, 2019. Available at: www.pcds.org.uk/ee/images/uploads/general/Adult_Eczema_Pathway-web.pdf
  8. Mortz C, Brockow K, Bindslev-Jensen C, Broesby-Olsen S. It looks like childhood eczema but is it? Clin Exp Allergy 2019; 49 (6): 744–753.
  9. NHS. Symptoms—atopic eczema. www.nhs.uk/conditions/atopic-eczema/symptoms/ (accessed 5 March 2020).
  10. Oliveira C, Torres T. More than skin deep: the systemic nature of atopic dermatitis. Eur J Dermatol 2019; 29 (3): 250–258.
  11. Yang E, Beck K, Sekhon S et al. The impact of pediatric atopic dermatitis on families: a review. Pediatr Dermatol 2019; 36 (1): 66–71.
  12. Le Roux E, Powell K, Banks J, Ridd M. GPs’ experiences of diagnosing and managing childhood eczema: a qualitative study in primary care. Br J Gen Pract 2018; 68 (667): e73–e80.
  13. NHS website. Atopic eczema. Causes. www.nhs.uk/conditions/atopic-eczema/causes/ (accessed 5 March 2020).
  14. National Eczema Society. Eczema and swimming factsheet. London: NES, 2019. Available at: eczema.org/documents/522
  15. Sala-Cunill A, Lazaro M, Herráez L et al. Basic skin care and topical therapies for atopic dermatitis: essential approaches and beyond. J Investig Allergol and Clin Immunol 2018; 28 (6): 379–391.
  16. van Zuuren E, Fedorowicz Z, Christensen R et al. Emollients and moisturisers for eczema (Review). Cochrane Database Syst Rev 2017; 2: CD012119.
  17. National Eczema Society. Emollients factsheet. London: NES, 2019. Available from: www.eczema.org/documents/459
  18. Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol 2018; 14 (Suppl. S2): 52.
  19. PCDS. Eczema—atopic eczema. www.pcds.org.uk/clinical-guidance/atopic-eczema (accessed 5 March 2020).
  20. NICE. Tacrolimus and pimecrolimus for atopic eczema. NICE Technology Appraisal Guidance 82. NICE, 2004. Available at: www.nice.org.uk/guidance/ta82
  21. Remitz A, De Pità O, Mota A et al. Position statement: topical calcineurin inhibitors in atopic dermatitis. J Eur Acad Dermatol Venereol 2018; 32 (12): 2074–2082.
  22. Ohtsuki M, Morimoto H, Nakagawa H. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: review on safety and benefits. J Dermatol 2018; 45 (8): 936–942.
  23. Al-Khenaizan S. Practical tip. Precooling topical calcineurin inhibitors tube; reduces burning sensation. Dermatol Online J 2010; 16 (4): 16.
  24. Robison R, Singh A. Controversies in allergy: food testing and dietary avoidance in atopic dermatitis. J Allergy Clin Immunol Pract 2019; 7 (1): 35–39.
  25. Wernham A, Veitch D, Grindlay D et al. What’s new in atopic eczema? An analysis of systematic reviews published in 2017. Part 1: treatment and prevention. Clin Exp Dermatol 2019; 44 (8): 861–867.
  26. Jewell J, Myers S. Topical therapy primer for nondermatologists. Med Clin North Am 2015; 99 (6): 1167–1182.
  27. Matterne U, Böhmer M, Weisshaar E et al. Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema (Review). Cochrane Database Syst Rev 2019, 1: CD012167.
  28. Levy M. Developing an eczema action plan. Clin Dermatol 2018; 36 (5): 659–661.
  29. Centre for Academic Primary Care, University of Bristol. Eczema written action plan. www.bristol.ac.uk/primaryhealthcare/researchthemes/apache/ewap/ (accessed 18 February 2020).